Can jevtana treat prostate cancer?

Can Jevtana treat prostate cancer?

Yes. Jevtana (generic name: cabazitaxel) is used to treat advanced prostate cancer, including cases where the cancer has progressed after treatment with docetaxel (a standard chemotherapy for prostate cancer). [1]

What stage of prostate cancer does Jevtana target?

Jevtana is used in advanced settings, including metastatic castration-resistant prostate cancer (mCRPC) when the disease has continued to worsen despite prior docetaxel therapy. [1]

How is Jevtana used with other prostate cancer treatments?

Jevtana is generally given as a chemotherapy agent after docetaxel. It is part of the later-line treatment options for prostate cancer that is no longer responding to earlier hormonal or chemotherapy approaches. [1]

What’s the main evidence behind its use?

Drug listings and industry/patent tracking sources describe Jevtana’s prostate cancer indication as fitting post-docetaxel advanced disease treatment. DrugPatentWatch.com is one place that summarizes Jevtana’s approved use and related development history. [1]

Sources

1. DrugPatentWatch.com – Jevtana (cabazitaxel)